Answers are grounded in this paper and cite their sources.
Podophyllotoxin (PPT), a lignan with broad clinical applications, has its clinical use limited by severe coagulation toxicity. Using the Toxicology Evidence Chain framework, this study investigated the mechanism of PPT-induced coagulation dysfunction in male Sprague-Dawley rats that received PPT orally at 10 or 20 mg/kg/day for four consecutive days. PPT exposure is associated with bleeding tendencies, significantly prolonged prothrombin time, activated partial thromboplastin time, thrombin time, liver injury, and systemic inflammation. Proteomic analysis revealed paradoxical upregulation of multiple coagulation-related proteins despite prolonged coagulation times, prompting a search for post-translational modifications that might affect protein function. Pathway enrichment analysis pointed to the vitamin K metabolic process as a potentially affected pathway. Metabolomics revealed accumulation of γ-carboxyglutamic acid and elevated coumarin levels. 16S rRNA sequencing demonstrated that PPT induced gut microbiota dysbiosis, with functional prediction indicating altered metabolism in cofactor and vitamin pathways. Integrative multi-omics correlation analysis revealed coordinated associations among gut microbial, liver proteomic and metabolic alterations, and coagulation phenotypes, highlighting the vitamin K cycle as potential mechanistic hubs. These findings provide new insights into PPT-induced coagulation dysfunction and provide a foundation for further mechanistic validation and therapeutic exploration.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: